NEWS
- Apr 28, 2025 News Release TAUNS Laboratories, Inc. has Concluded a Capital and Business Alliance Agreement with Craif Inc., a Startup Developing Urinary MicroRNA-Based Tests for Early Cancer Detection. New
- Apr 04, 2025 News Release Notice of Capital and Business Alliance with Aillis, Inc.and Acquisition of Shares through Third-Party Allocation of New Shares.
- Apr 01, 2025 News Release TAUNS Laboratories, Inc. has Concluded a Capital and Business Alliance Agreement with KINS Co., Ltd., a Healthcare Startup Specializing in Microbiomes.
- Feb 06, 2025 News Release Notice of Strategic Business Alliance with ZACROS Corporation
- Jan 28, 2025 News Release Patent on Method and Reagent for Detecting Target Substance Granted in Japan
- Apr 28, 2025 News Release TAUNS Laboratories, Inc. has Concluded a Capital and Business Alliance Agreement with Craif Inc., a Startup Developing Urinary MicroRNA-Based Tests for Early Cancer Detection. New
- Apr 04, 2025 News Release Notice of Capital and Business Alliance with Aillis, Inc.and Acquisition of Shares through Third-Party Allocation of New Shares.
- Apr 01, 2025 News Release TAUNS Laboratories, Inc. has Concluded a Capital and Business Alliance Agreement with KINS Co., Ltd., a Healthcare Startup Specializing in Microbiomes.
- Feb 06, 2025 News Release Notice of Strategic Business Alliance with ZACROS Corporation
- Jan 28, 2025 News Release Patent on Method and Reagent for Detecting Target Substance Granted in Japan
- Sep 01, 2021 Notice Announcement of Website Renewal
- Nov 18, 2019 Notice 2019/11/18-21 Exhibit at MEDICA 2019
- Nov 12, 2018 Notice 2018/11/12-15 Exhibit at MEDICA 2018
- Jul 31, 2018 Notice 2018/7/31-8/2 Exhibit at 70th AACC
- Nov 13, 2017 Notice 2017/11/13-16 Exhibit at MEDICA 2017
We will accumulate technology and knowledge, and continue to develop and improve our products.
Investors News
Investors
